CCHR NEWSLETTER: Psychiatric Inpatients Have Elevated Risks for Adverse Reactions

Psychiatric Inpatients Have Elevated Risks for Adverse Reactions

 

[Reference: “Multiple adverse outcomes following first discharge from inpatient psychiatric care: a national cohort study”, The Lancet Psychiatry, June 03, 2019]

People discharged from inpatient psychiatric care are at higher risk than the rest of the population for a range of serious fatal and non-fatal adverse outcomes.

These individuals are also more likely to perpetrate violent crimes, including homicide. Suicide risk is known to be especially raised soon after discharge.

READ NEWSLETTER

VLA commewnt:

I would encourage eveRyone to go to our pharmacogenetic “room”.  Millions of inpatients are being given  modern drugs for diagnoses of Bipolar, ADHD that they can’t metabolize.  By giving the inpatients drugs that are cookie cutter prescribed without the duty to care genetic test to see if the drug they are being prescribed can be adequately metabolized.  Cultural groups such as Caucasian, African Americans, Asians have different panels of enyzmes per culture.  For example 10% of Caucasians are genetically missing the liver enzyme that metabolized common psychiatric drugs such as Haldol, Respiradol, Adderall and street drugs such as cocaine, psyilosybn, LSD, etc.  When given cookie cutter prescriptions, taken on a daily  basis,  this demographic begin to have suicidal or homicidal ideations because the drug is accumulating in the body, not able to transduce by enzymatic activity into a harmless substance to be excreted out by the kidneys.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.